Devices › Device types
FDA product code GXD · class 2 · Neurology
Generator, lesion, radiofrequency: medical device reports filed with FDA
1,825 reports carry this product code, 1992–2026; 5 brands with a page.
- 1,825
- reports with this product code
- 0% of all MAUDE reports
- 68
- reports, 12 months to August 2026
- 94 in the 12 months before
- 53.8%
- classified as malfunction
- 62.3% across all reports
- 0.3%
- classified as death, as reported
- 0.9% across all reports
Product code GXD is FDA's classification for "Generator, lesion, radiofrequency" (neurology panel), a class 2 device. 1,825 medical device reports carry this product code, 0% of the MAUDE database, from July 1992 to August 2026.
68 reports arrived in the 12 months to August 2026, down 28% from 94 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (53.8%), injury (41.9%) and other (3.4%). 5 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| 4 Lesion NT2000 Pain Management RF Generator | 395 | 3 | 0% | 42.3% |
| 3 Lesion Nt1100 Pain Management Rf Generator | 170 | 0 | 0% | 27.6% |
| Ampere RF Ablation Generator | 3 | 14 | 1.1% | 55.9% |
| Stockert 70 Rf Generator | 2 | 0 | 4.2% | 33.5% |
| Constellation With Laser | 1 | 0 | 0.1% | 78.4% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| St Jude Medical | 405 | 22.2% |
| Stryker Instruments Kalamazoo | 138 | 7.6% |
| Stryker Instruments-Kalamazoo | 67 | 3.7% |
| Stryker Instruments-A Division Of Stryker | 45 | 2.5% |
| Boston Scientific Neuromodulation | 22 | 1.2% |
| Covidien Valleylab | 14 | 0.8% |
| Avanos Medical | 10 | 0.5% |
| Medtronic Neuromodulation | 6 | 0.3% |
| Stryker Osteosynthesis Freiburg | 6 | 0.3% |
| Baylis Medical | 3 | 0.2% |
| Stryker Endoscopy Puerto Rico | 3 | 0.2% |
| Stryker Instruments | 3 | 0.2% |
| Valleylab | 3 | 0.2% |
| Biosense Webster | 1 | 0.1% |
| Horizon Medical Products | 1 | 0.1% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Temperature problem | 138 | 7.6% |
| Device operates differently than expectedthe device behaved unexpectedly | 137 | 7.5% |
| Insufficient heating | 136 | 7.5% |
| Device displays incorrect message | 106 | 5.8% |
| Output problem | 86 | 4.7% |
| Fracturea broken bone | 77 | 4.2% |
| Insufficient device problem information | 72 | 3.9% |
| Communication or transmission problemthe device could not communicate or transmit | 68 | 3.7% |
| Self-activation or keying | 66 | 3.6% |
| Failure to power up | 53 | 2.9% |
| Smoking | 41 | 2.2% |
| Thermal decomposition of device | 40 | 2.2% |
| High impedance | 34 | 1.9% |
| Unexpected shutdown | 33 | 1.8% |
| Impedance problem | 29 | 1.6% |
| Connection problema connection problem | 27 | 1.5% |
| Device inoperablethe device could not be used | 27 | 1.5% |
| Overheating of device | 25 | 1.4% |
| Material deformation | 24 | 1.3% |
| Failure to deliver energy | 23 | 1.3% |
Questions about generator, lesion, radiofrequency reports
What is product code GXD?
FDA's classification code for "Generator, lesion, radiofrequency", class 2, reviewed by the neurology panel. Every device report carries the product code of the device involved.
How many reports carry this code?
1,825 reports through August 2026, 68 of them in the latest 12 months.
Which brands appear most often?
4 Lesion NT2000 Pain Management RF Generator (395), 3 Lesion Nt1100 Pain Management Rf Generator (170), Ampere RF Ablation Generator (3), Stockert 70 Rf Generator (2) and Constellation With Laser (1). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.